Annual Accounts Payable
$3.19 M
-$1.95 M-37.98%
December 31, 2023
Summary
- As of February 26, 2025, BCAX annual accounts payable is $3.19 million, with the most recent change of -$1.95 million (-37.98%) on December 31, 2023.
- During the last 3 years, BCAX annual accounts payable has fallen by -$1.95 million (-37.98%).
- BCAX annual accounts payable is now -37.98% below its all-time high of $5.14 million, reached on December 31, 2022.
Performance
BCAX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.96 M
-$2.72 M-58.10%
September 30, 2024
Summary
- As of February 26, 2025, BCAX quarterly accounts payable is $1.96 million, with the most recent change of -$2.72 million (-58.10%) on September 30, 2024.
- Over the past year, BCAX quarterly accounts payable has dropped by -$1.22 million (-38.42%).
- BCAX quarterly accounts payable is now -58.10% below its all-time high of $4.68 million, reached on June 30, 2024.
Performance
BCAX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
BCAX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.0% | -38.4% |
| 3 y3 years | -38.0% | -38.4% |
| 5 y5 years | -38.0% | -38.4% |
BCAX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.0% | at low | -58.1% | at low |
| 5 y | 5-year | -38.0% | at low | -58.1% | at low |
| alltime | all time | -38.0% | at low | -58.1% | at low |
Bicara Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.96 M(-58.1%) |
| Jun 2024 | - | $4.68 M(+47.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $3.19 M(-38.0%) | $3.19 M |
| Dec 2022 | $5.14 M | - |
FAQ
- What is Bicara Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Bicara Therapeutics?
- What is Bicara Therapeutics annual accounts payable year-on-year change?
- What is Bicara Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Bicara Therapeutics?
- What is Bicara Therapeutics quarterly accounts payable year-on-year change?
What is Bicara Therapeutics annual accounts payable?
The current annual accounts payable of BCAX is $3.19 M
What is the all time high annual accounts payable for Bicara Therapeutics?
Bicara Therapeutics all-time high annual accounts payable is $5.14 M
What is Bicara Therapeutics annual accounts payable year-on-year change?
Over the past year, BCAX annual accounts payable has changed by -$1.95 M (-37.98%)
What is Bicara Therapeutics quarterly accounts payable?
The current quarterly accounts payable of BCAX is $1.96 M
What is the all time high quarterly accounts payable for Bicara Therapeutics?
Bicara Therapeutics all-time high quarterly accounts payable is $4.68 M
What is Bicara Therapeutics quarterly accounts payable year-on-year change?
Over the past year, BCAX quarterly accounts payable has changed by -$1.22 M (-38.42%)